Greece wants to triple the share of generic drugs prescribed by the end of next year, closing the gap to targets set by international creditors under the terms of the country’s bailout, Health Minister Adonis Georgiades said.
Teva Pharmaceutical Industries Ltd. is using records from its 24-hour support hotline in the U.S. to persuade thousands of multiple sclerosis patients to switch from its biggest-selling drug, Copaxone, to a new version that has patent protection until 2030.
U.S. regulators are mobilizing to shore up confidence in America’s generic-drug supply as alarm grows over the quality of products made in India, and the head of the largest U.S.-based maker of the medicines predicted more trouble lies ahead.
Senator Ron Wyden, an Oregon Democrat, said in an interview with Bloomberg Television’s “Political Capital with Al Hunt,” airing this weekend, that one his priorities as the new chairman of the Senate Finance Committee will be renew about 50 U.S. tax credits and deductions that expired as last year ended.
Nestle SA paid $3.6 billion yesterday to take full control of Galderma, the dermatology business that revives skin. Nestle Chief Executive Officer Paul Bulcke will need to do the same at the unit to spur growth.
Relatives of heroin addicts should be allowed to keep an overdose antidote available as use of the illegal drug surges in the U.S., prompted by increased abuse of prescription painkillers, federal drug officials said.
CVS Caremark, the largest provider of prescription drugs in the U.S., plans to stop selling cigarettes and tobacco-related products across the nation by Oct. 1 in an effort to support the health of its patients and customers.